Press release
August 31, 2026
Arcturus Therapeutics to Participate in Upcoming Investor Conferences
Arcturus Therapeutics Holdings Inc. (ARCT)
SAN DIEGO --(BUSINESS WIRE)--Aug. 31, 2026-- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today announced that the Company will participate in the